Mereo BioPharma Group plc (MREO) Executive Compensation
Mereo BioPharma Group plc (MREO) is a publicly traded company on the Nasdaq, categorized under SIC 2834 (Pharmaceutical Preparations). Access real-time SEC filings, 10-K annual reports, 10-Q quarterlies, 8-K current reports, PCAOB auditor history, and executive compensation disclosures.
Ticker: MREO
CIK: 1719714
Exchange: Nasdaq
SIC 2834: Pharmaceutical Preparations
Fiscal Year End: 12/31
State: X0
Independent PCAOB Auditor
Explore PCAOB Audit Intelligence →
Audit Firm
PricewaterhouseCoopers LLP
Auditor SinceSince 12/31/2023 12:00:00 AM
Lead Engagement PartnerSam Taylor
Audit LocationReading, United Kingdom
Latest SEC EDGAR Filings
Showing 10-K, 10-Q, 8-K, Form 4, and other SEC submissions| Form | Filing Date | Reporting Period | Description | Accession Number | Actions |
|---|---|---|---|---|---|
| 8-K | 2026-08-19 | 2026-08-18 | 8-K | 0001193125-26-356168 | View SEC Doc Filr Page |
| SCHEDULE 13G/A | 2026-08-14 | — | SCHEDULE 13G/A Filing | 0000935836-26-000413 | View SEC Doc Filr Page |
| 10-Q | 2026-08-11 | 2026-06-30 | 10-Q | 0001193125-26-343533 | View SEC Doc Filr Page |
| 8-K | 2026-08-11 | 2026-08-11 | 8-K | 0001193125-26-343519 | View SEC Doc Filr Page |
| 8-K | 2026-08-11 | 2026-08-11 | 8-K | 0001193125-26-343482 | View SEC Doc Filr Page |
| SCHEDULE 13G/A | 2026-05-15 | — | SCHEDULE 13G/A Filing | 0000935836-26-000265 | View SEC Doc Filr Page |
| SCHEDULE 13G | 2026-05-14 | — | SCHEDULE 13G Filing | 0000070858-26-000293 | View SEC Doc Filr Page |
| 8-K | 2026-05-14 | 2026-05-14 | 8-K | 0001193125-26-223071 | View SEC Doc Filr Page |
| 8-K/A | 2026-05-12 | 2026-05-12 | 8-K/A | 0001193125-26-218290 | View SEC Doc Filr Page |
| 10-Q | 2026-05-12 | 2026-03-31 | 10-Q | 0001193125-26-218232 | View SEC Doc Filr Page |
| 8-K | 2026-05-12 | 2026-05-12 | 8-K | 0001193125-26-218192 | View SEC Doc Filr Page |
| ARS | 2026-04-09 | 2025-12-31 | ARS | 0001193125-26-148835 | View SEC Doc Filr Page |
| DEF 14A | 2026-04-09 | 2026-04-08 | DEF 14A | 0001193125-26-148832 | View SEC Doc Filr Page |
| PRE 14A | 2026-03-27 | 2026-03-27 | PRE 14A | 0001193125-26-127271 | View SEC Doc Filr Page |
| 8-K | 2026-03-27 | 2026-03-26 | 8-K | 0001193125-26-127253 | View SEC Doc Filr Page |
| 10-K | 2026-03-19 | 2025-12-31 | 10-K | 0001193125-26-115226 | View SEC Doc Filr Page |
| 8-K | 2026-03-19 | 2026-03-19 | 8-K | 0001193125-26-115211 | View SEC Doc Filr Page |
| 4 | 2026-02-27 | 2026-02-26 | 4 | 0001193125-26-082831 | View SEC Doc Filr Page |
| 4 | 2026-02-27 | 2026-02-26 | 4 | 0001193125-26-082830 | View SEC Doc Filr Page |
| 4 | 2026-02-27 | 2026-02-26 | 4 | 0001193125-26-082826 | View SEC Doc Filr Page |
| 4 | 2026-02-27 | 2026-02-26 | 4 | 0001193125-26-082820 | View SEC Doc Filr Page |
| 4 | 2026-02-27 | 2026-02-26 | 4 | 0001193125-26-082838 | View SEC Doc Filr Page |
| 4 | 2026-02-27 | 2026-02-26 | 4 | 0001193125-26-082818 | View SEC Doc Filr Page |
| 4 | 2026-02-27 | 2026-02-26 | 4 | 0001193125-26-082835 | View SEC Doc Filr Page |
| 4 | 2026-02-27 | 2026-02-26 | 4 | 0001193125-26-082815 | View SEC Doc Filr Page |